OPRX Stock Summary and Trading Ideas (Optimizerx | NASDAQ:OPRX)

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Optimizerx trades on the NASDAQ stock market under the symbol OPRX.

As of February 27, 2026, OPRX stock price declined to $7.58 with 291,486 million shares trading.

OPRX has a beta of 1.85, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.12 to the broad based SPY ETF.

OPRX has a market cap of $140.16 million. This is considered a Micro Cap stock.

Last quarter Optimizerx reported $26 million in Revenue and $.20 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.21.

In the last 3 years, OPRX traded as high as $22.25 and as low as $3.78.

The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, IWM, VXF, IWO, FDLS.

OPRX has outperformed the market in the last year with a return of +47.5%, while the SPY ETF gained +18.5%. However, in the most recent history, OPRX shares have underperformed the stock market with its stock returning -50.7% in the last 3 month period and -13.4% for the last 2 week period, while SPY has returned +1.2% and +0.6%, respectively.

OPRX support price is $7.35 and resistance is $8.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX shares will trade within this expected range on the day.